CV Sciences, Inc.
CVSI- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001510964
In the last 90 days, CV Sciences, Inc. insiders filed 1 open-market purchase and 0 sales; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by CV Sciences, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 1 filing
- 1 insider, $114.8K in total
- Open-market sells
- 0 filings
- Insiders trading
- 1
- Net value
- +$114.8K
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for CV Sciences, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Cheever Charlie E III | 10% Owner | 26,648,711 | Sep 9, 2026 | 1 |
| Dowling Joseph D | Chief Executive Officer | – | Feb 20, 2025 | 0 |
| Grasser Joerg | Chief Financial Officer | – | Feb 20, 2025 | 0 |
| Corroon James Michael Jr. | Director | – | Feb 20, 2025 | 0 |
| McCorkle William | Director | – | Feb 20, 2025 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 9, 2026 (view filing)6:43 PM ET | Jul 16-Aug 7 | 55 daysLate | Cheever Charlie E III10% Owner | PPurchaseCommon Stock, $0.0001 par value per share | +5.74M | $0.02 | +$114.8K | +27.5%26.6M after | 10 lots |